Showing 1 - 5 results of 5 for search 'Daniël M. F. Claassens', query time: 0.03s Refine Results
  1. 1
    Is there a place for heart-type fatty acid binding protein in the era of high-sensitive cardiac troponin T for the diagnosis of acute myocardial infarction? A systematic review

    Is there a place for heart-type fatty acid binding protein in the era of high-sensitive cardiac troponin T for the diagnosis of acute myocardial infarction? A systematic review by Daniel M.F. Claassens, Djura O. Coers, Thomas O. Bergmeijer, Dean R.P.P. Chan Pin Yin, Jurriën M. Ten Berg

    Published 2019-06-01
    Get full text
    Article
  2. 2
    Effects of CYP3A4*22 and CYP3A5 on clinical outcome in patients treated with ticagrelor for ST-segment elevation myocardial infarction: POPular Genetics sub-study

    Effects of CYP3A4*22 and CYP3A5 on clinical outcome in patients treated with ticagrelor for ST-segment elevation myocardial infarction: POPular Genetics sub-study by Jaouad Azzahhafi, Thomas O. Bergmeijer, Wout W. A. van den Broek, Dean R. P. P. Chan Pin Yin, Senna Rayhi, Joyce Peper, Willem L. Bor, Daniel M. F. Claassens, Daniel M. F. Claassens, Ron H. N. van Schaik, Jurriën M. ten Berg, Jurriën M. ten Berg

    Published 2022-12-01
    Get full text
    Article
  3. 3
    Factor V Leiden and the Risk of Bleeding in Patients With Acute Coronary Syndromes Treated With Antiplatelet Therapy: Pooled Analysis of 3 Randomized Clinical Trials

    Factor V Leiden and the Risk of Bleeding in Patients With Acute Coronary Syndromes Treated With Antiplatelet Therapy: Pooled Analysis of 3 Randomized Clinical Trials by Bakhtawar K. Mahmoodi, Niclas Eriksson, Stephanie Ross, Daniel M. F. Claassens, Folkert W. Asselbergs, Karina Meijer, Agneta Siegbahn, Stefan James, Guillaume Pare, Lars Wallentin, Jurriën M. ten Berg

    Published 2021-09-01
    Get full text
    Article
  4. 4
    Bedside testing of CYP2C19 gene for treatment of patients with PCI with antiplatelet therapy

    Bedside testing of CYP2C19 gene for treatment of patients with PCI with antiplatelet therapy by Abdullah M. Al-Rubaish, Fahad A. Al-Muhanna, Abdullah M. Alshehri, Mohammed A. Al-Mansori, Rudaynah A. Alali, Rania M. Khalil, Khalid A. Al Faraidy, Cyril Cyrus, Mohammed M. Sulieman, Chittibabu Vatte, Daniel M. F. Claassens, Jurriën M. ten Berg, Folkert W. Asselbergs, Amein K. Al-Ali

    Published 2020-06-01
    Get full text
    Article
  5. 5
    Rationale and Design of the Future Optimal Research and Care Evaluation in Patients with Acute Coronary Syndrome (FORCE-ACS) Registry: Towards “Personalized Medicine” in Daily Clinical Practice

    Rationale and Design of the Future Optimal Research and Care Evaluation in Patients with Acute Coronary Syndrome (FORCE-ACS) Registry: Towards “Personalized Medicine” in Daily Clin... by Dean R. P. P. Chan Pin Yin, Gert-Jan A. Vos, Niels M. R. van der Sangen, Ronald Walhout, R. Melvyn Tjon Joe Gin, Deborah M. Nicastia, Jorina Langerveld, Daniël M. F. Claassens, Marieke E. Gimbel, Jaouad Azzahhafi, Willem L. Bor, Tom Oirbans, Johan Dekker, Georgios J. Vlachojannis, Rutger J. van Bommel, Yolande Appelman, José P. S. Henriques, Wouter J. Kikkert, Jurriën M. ten Berg

    Published 2020-09-01
    Get full text
    Article

Search Tools: